Construmat Showcases the Transformation of Construction Towards Sustainability
BARCELONA, Spain, May 14, 2025 /PRNewswire/ -- From May 20 to 22, Construmat returns as Spain's leading trade fair for the construction industry, expanding in number of companies, international presence and scale. It will showcase technologies, systems, and materials aimed at advancing more sustainable and efficient construction models. The Fira de Barcelona event will also offer ideas and experiences to reduce the sector's environmental impact, increase digitalization, attract talent, and address the housing shortage crisis.
In its 24th edition, Construmat will gather over 350 exhibitors from 22 countries in Barcelona, expecting to exceed 22,000 visitors. The fair has grown by 24% in participating companies and 15% in occupied space compared to last year.
With a commercial offering focused on sustainability and efficiency improvement, Construmat presents the latest in machinery and tools, industrialized construction, walls, structures, façades and roofs, insulation, waterproofing, urban planning and outdoor spaces, design and interior design, flooring and cladding, BIM and ICT for projects and construction, kitchens, bathrooms, lighting, energy management and capture, installations, enclosures, carpentry, locksmithing, and solar protection, among others.
This year, the fair has increased its international presence, with 35% of the commercial exhibition coming from outside Spain. Companies and group pavilions from France, Germany, Portugal, China, Poland, Belgium, Austria, Morocco, Italy, the UK, the Netherlands, Egypt, Andorra, Lithuania, Hungary, and Japan will participate.
Turkey will be the guest country, with over 20 exhibitors—mainly manufacturers of construction materials and machinery. Turkey will also feature prominently in the fair's activity program, sharing success stories and participating in business meetings with a strong commercial and institutional delegation.
Disruptive Startups
The commercial area will also host 40 startups offering technological solutions to optimize processes, reduce costs, and improve efficiency in the construction sector. Innovations include nanocoatings to enhance material functionality and durability, sensors for real-time concrete strength monitoring, and systems for infrastructure analysis using drones and 3D technology. This area will also feature talks, pitching sessions, and networking opportunities for startups to present their projects to potential investors, buyers, and partners.
Congress, sessions, and workshops
The fair will offer 120 activities, including the standout Sustainable Building Congress. Over 100 national and international speakers will address topics such as affordable social housing, building health and biohabitability, and practical applications of AI in architecture, construction, and public works. Keynote speakers include architects David Adjaye, Peris + Toral, Stephen Bates, and Mohammed Adib.
Photo - https://mma.prnewswire.com/media/2686553/lab_construmat.jpgLogo - https://mma.prnewswire.com/media/659718/5317003/Fira_Barcelona_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/construmat-showcases-the-transformation-of-construction-towards-sustainability-302454436.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Monk Fruit Sweeteners Market to Reach $147.2 Million by 2032, Driven by Health Consciousness and Clean-Label Trends, Says Meticulous Research®
A new report by Meticulous Research® forecasts the global monk fruit sweeteners market to grow at a CAGR of 4.5% from 2025 to 2032 REDDING, Calif., June 30, 2025 /PRNewswire/ -- According to a comprehensive market research report titled "Monk Fruit Sweeteners Market Size, Share, Forecast, & Trends Analysis by Product Type (Monk Fruit Extract), Form (Solid), Category (Organic), Packaging Type, Application (Beverages, Food), Distribution Channel (B2B) - Global Forecast to 2032," the monk fruit sweeteners market is projected to reach $147.2 million by 2032, up from an estimated $107.9 million in 2025, growing at a steady CAGR of 4.5% during the forecast period. Market Segmentation Highlights: By Product Type: Monk fruit extracts dominate market with versatile applications in baked goods, beverages, and dietary supplements Monk fruit juice concentrates gaining adoption for natural beverage formulations Monk fruit infusions expanding in specialty health and wellness product categories Concentrated sweetness enabling manufacturers to use smaller quantities for desired sweetness levels To explore the complete report, visit: By Form: Solid form leads with 68.7% market share due to ease of handling, storage, and superior shelf life Liquid form gaining traction in beverage applications and processing convenience Solid formulations preferred for bakery, confectionery, and dry mix applications Versatility across multiple applications driving solid form market dominance By Category: Conventional segment maintaining larger market share with rising consumer demand for natural alternatives Organic segment projected to register highest CAGR with premium food product demand Certified organic products expanding in food & beverage industry applications Clean-label and sugar-free alternatives driving both conventional and organic segment growth By Application Analysis: Beverages segment accounts for 45.3% market share with health benefits and sugar-free product development Food applications expanding with natural sweetening solutions for dairy, bakery, and confectionery Nutrition & health supplements growing with zero-calorie and low glycemic index benefits Natural health and sports drinks with enhanced nutritional value supporting beverage segment growth Regional Market Leadership: North America dominates with 52.8% market share, driven by health consciousness and diabetes awareness Asia-Pacific expected to grow at highest CAGR of 5.1% with China as world's largest monk fruit producer Europe showing significant growth opportunities with clean-label product demand Latin America emerging as high-potential market with rising interest in natural sweeteners Key Market Drivers: Increasing health consciousness among consumers seeking natural, zero-calorie sugar alternatives Growing demand for organic and natural food & beverage products with clean-label attributes Rising prevalence of diabetes and obesity driving low-calorie sweetener adoption Product innovations including 100-250 times sweetness compared to traditional sugar Consumer preference for ingredients free from artificial additives and GMO components Clean-label trend with 78% of global consumers willing to pay premium for transparent products Emerging Market Opportunities: Increasing demand for monk fruit sweeteners in Europe and Latin America markets Rising consumer interest in natural sweeteners replacing artificial alternatives Growing demand for clean-label products emphasizing transparency and natural ingredients Premium positioning of organic monk fruit sweeteners in health-conscious consumer segments Integration with functional foods providing antioxidant effects and blood sugar regulation For more comprehensive insights, download the FREE report sample: Market Challenges: Stringent government regulations affecting product approval and market entry processes Higher prices compared to artificial sweeteners limiting mass market adoption Limited consumer awareness in emerging markets about monk fruit sweetener benefits Supply chain complexities with China as primary source of monk fruit production Insights from the Meticulous Research® Analyst Team: "The monk fruit sweeteners market represents a significant opportunity in the natural sweetener space, with diabetes cases projected to increase from 537 million to 783 million by 2045, driving demand for zero-calorie alternatives. Our research indicates Asia-Pacific will lead growth at 5.1% CAGR, leveraging China's production capabilities and traditional medicine heritage," said Mr. Uddhav Sable, Research Director at Meticulous Research®. Competitive Landscape: Leading market players include Monk Fruit Corp., Guilin Layn Natural Ingredients Corp., Archer-Daniels-Midland Company, GLG Life Tech Corporation, Apura Ingredients Inc., DSM-Firmenich AG, Hunan Huacheng Biotech Inc., Tate & Lyle PLC, Foodchem International Corporation, Whole Earth Sweetener Co. LLC, Lakanto, and Steviva Brands Inc., focusing on product innovation, organic offerings, and strategic partnerships with food & beverage manufacturers. Request a customized research analysis tailored to your specific requirements: About the Report: The 280-page report provides detailed insights into: Market Size & Forecast Analysis (2025–2032) Product Type Performance Benefits & Application Versatility Form Requirements & Packaging Solutions Regional Growth Opportunities & Consumer Behavior Analysis Competitive Landscape & Strategic Product Development Clean-Label Trends & Premium Product Positioning Immediate Delivery Available | Buy this Research Report: Related Reports: Natural Sweeteners Market Size, Share, Trends Analysis 2032 Fruit and Vegetable Ingredients Market Size, Share & Growth Report 2032 Organic Food Market by Size, Share, Forecasts, & Trends Analysis Functional Beverages Market Size, Share, Trends 2031 Juice Concentrates Market: Trends, & Future Growth Analysis About Meticulous Research®: We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth since 2010. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact: Mr. Khushal Bombe Meticulous Market Research Pvt. Ltd. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe: +44-203-868-8738 APAC: +91 744-7780008 Email- sales@ Visit Our Website: Connect with us on LinkedIn- Content Source: Logo - View original content to download multimedia: SOURCE Meticulous Market Research Pvt. Ltd. Sign in to access your portfolio
Yahoo
10 hours ago
- Yahoo
Halozyme Therapeutics Added to Russell 1000® Index
SAN DIEGO, June 30, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that it has been added to the U.S. large-cap Russell 1000® Index, effective after market close on June 27th, as part of the 2025 FTSE Russell indexes annual reconstitution. The Russell 1000® Index includes approximately 1,000 of the largest U.S. securities based on market capitalization and is widely used by investors as a benchmark for the performance of large-cap stocks. "Joining the Russell 1000 Index is an important milestone that reflects our leadership in rapid large-volume subcutaneous drug delivery and our track record of durable top-and-bottom line growth," said Dr. Helen Torley, President and CEO of Halozyme. "The inclusion will help to expand our visibility among the investment community as we continue to execute our strategy and deliver sustainable growth and profitability well into the future." The Russell 1000® is managed by FTSE Russell, a global leader in index and analytics. Membership in the Russell 1000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index. About Halozyme Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE® drug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and Acumen Pharmaceuticals. Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, reliability and tolerability, and enhanced patient comfort and adherence. The Company has two commercial proprietary products, Hylenex® and XYOSTED®, partnered commercial products and ongoing product development programs with Teva Pharmaceuticals and McDermott Laboratories Limited, an affiliate of Viatris Inc. Halozyme is headquartered in San Diego, CA and has offices in Ewing, NJ and Minnetonka, MN. Minnetonka is also the site of its operations facility. For more information visit and connect with us on LinkedIn and Twitter. Safe Harbor Statement In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning the future execution of Halozyme's strategy and delivery of future sustainable growth and profitability, the durability of Halozyme's top and bottom line growth, the possible activity, benefits and attributes of ENHANZE®, the possible method of action of ENHANZE®, its potential application to aid in the dispersion and absorption of other injected therapeutic drugs, and statements concerning certain other potential benefits of ENHANZE® including facilitating more rapid delivery of injectable medications through subcutaneous delivery and potentially lowering the treatment burden for patients. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are typically, but not always, identified through use of the words "expect," "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected results in the execution of Halozyme's strategy and unexpected future financial results and top and bottom line growth,. These and other factors that may result in differences are discussed in greater detail in Halozyme's most recent Annual and Quarterly Reports filed with the Securities and Exchange Commission. Except as required by law, Halozyme undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate Communications609-333-7668tbui@ Sydney View original content to download multimedia: SOURCE Halozyme Therapeutics, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
ONEOK Second Quarter 2025 Conference Call and Webcast Scheduled
TULSA, Okla., June 30, 2025 /PRNewswire/ -- ONEOK, Inc. (NYSE: OKE) will release second quarter 2025 earnings after the market closes on Aug. 4, 2025. Members of ONEOK's management team will participate in a conference call the following day. What: ONEOK second quarter 2025 earnings conference call and webcast When: 11 a.m. Eastern, Aug. 5, 202510 a.m. Central Where: 1) Phone conference call dial 877-883-0383, entry number 97069042) Log on to the webcast at If you are unable to participate in the conference call or the webcast, the replay will be available on ONEOK's website, for one year. A recording will be available by phone for seven days. The playback call may be accessed at 877-344-7529, access code 4363302. At ONEOK (NYSE: OKE), we deliver energy products and services vital to an advancing world. We are a leading midstream operator that provides gathering, processing, fractionation, transportation, storage and marine export services. Through our approximately 60,000-mile pipeline network, we transport the natural gas, natural gas liquids (NGLs), refined products and crude oil that help meet domestic and international energy demand, contribute to energy security and provide safe, reliable and responsible energy solutions needed today and into the future. As one of the largest integrated energy infrastructure companies in North America, ONEOK is delivering energy that makes a difference in the lives of people in the U.S. and around the world. ONEOK is an S&P 500 company headquartered in Tulsa, Oklahoma. For information about ONEOK, visit the website: For the latest news about ONEOK, find us on LinkedIn, Facebook, X and Instagram. Analyst Contact: Megan Patterson918-561-5325 Media Contact: Alicia Buffer918-861-3749 View original content to download multimedia: SOURCE ONEOK, Inc. Sign in to access your portfolio
